Dri, A.; Garattini, S.K.; Cinausero, M.; Macerelli, M.; Fanelli, M.; Puglisi, F.; Fasola, G.; Ermacora, P.
Rare and Insidious Toxicities from New Combination Therapies in Metastatic Renal Cell Cancer: Lessons Learned from Real-Practice. Curr. Oncol. 2022, 29, 6776-6786.
https://doi.org/10.3390/curroncol29100533
AMA Style
Dri A, Garattini SK, Cinausero M, Macerelli M, Fanelli M, Puglisi F, Fasola G, Ermacora P.
Rare and Insidious Toxicities from New Combination Therapies in Metastatic Renal Cell Cancer: Lessons Learned from Real-Practice. Current Oncology. 2022; 29(10):6776-6786.
https://doi.org/10.3390/curroncol29100533
Chicago/Turabian Style
Dri, Arianna, Silvio Ken Garattini, Marika Cinausero, Marianna Macerelli, Martina Fanelli, Fabio Puglisi, Gianpiero Fasola, and Paola Ermacora.
2022. "Rare and Insidious Toxicities from New Combination Therapies in Metastatic Renal Cell Cancer: Lessons Learned from Real-Practice" Current Oncology 29, no. 10: 6776-6786.
https://doi.org/10.3390/curroncol29100533
APA Style
Dri, A., Garattini, S. K., Cinausero, M., Macerelli, M., Fanelli, M., Puglisi, F., Fasola, G., & Ermacora, P.
(2022). Rare and Insidious Toxicities from New Combination Therapies in Metastatic Renal Cell Cancer: Lessons Learned from Real-Practice. Current Oncology, 29(10), 6776-6786.
https://doi.org/10.3390/curroncol29100533
